Illness	Number of cases
Parkinson disease (G20.11)	656
Parkinson disease (G20.21)	63
Other degenerative diseases of basal ganglia - Progressive supranuclear ophthalmoplegia Steele-Richardson-Olszewski (G23.1)	30
Chronic inflammatory disease of the nervous system - multiple sclerosis (G35.11)	16
Secondary parkinsonism - Vascular parkinsonism (G21.4)	14
Secondary parkinsonism - Other secondary parkinsonism (G21.8)	12
Chronic inflammatory disease of the nervous system - multiple sclerosis (G35.21)	7
Chronic inflammatory disease of the nervous system - multiple sclerosis (G35.31)	6
Cerebral infarction (I63.3)	5
Convulsions not elsewhere classified (R56.8)	5

Top 10 treatments

Treatment	Number
(Neuro-)psychological assessment or establishing the psychosocial background such as financial, occupational and family situation (1-901.0)	1.387
Examination of nerve conduction - ENG (1-206)	966
Measurement of smell and taste (1-247)	762
Patient education (9-500.0)	643
Measurement of the electrical activity of the heart without a tube (catheter) inserted into the heart via an artery (1-266.x)	638
Measurement of the brain waves - EEG (1-207.0)	525
Treatment of physically or functionally induced disorders of speech, language, the voice or swallowing (9-320)	498
Interdisciplinary management other chronic illnesses (8-97d.1)	459
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.2)	394
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.00)	250

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
7	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility